AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Discussing the Role of MRD in CLL With Talal Hilal, MD
The HemOnc Pulse
Challenges of Doublet Therapies Approval and MRD-guided Treatment Decisions in CLL
Exploring the obstacles faced in gaining approval for doublet therapies in the US for CLL treatment, to address individual drug approval regulations. Insights from the FLAIR trial highlight the use of MRD status for treatment decisions, along with the efficacy of combining BTK inhibitors with anti-CD20 antibodies for improved undetectable MRD rates.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode